Andover, MA, September 26, 2014 -- Neodent USA, Inc. (to be known as Instradent USA, Inc. from October 1, 2014) has responded to Nobel Biocare’s allegations of patent infringement filed in August in the Central District of California and related to one of its dental implants. In addition, Instradent has filed counterclaims against Nobel Biocare, which challenge the validity of the patents in question.
The counterclaims are based on strong evidence that will show the relevant authorities that the history of Patent 8,714,977 contains particularities, including limitations that were introduced at a later stage. On the basis of this and other evidence, Instradent claims that the patents were erroneously granted and should be invalidated. The counterclaim also includes a demand for declaratory judgment of non-infringement.
Tony Susino, CEO of Instradent USA commented: “Instradent is committed to observing valid patent rights. We are convinced that we have not infringed Nobel Biocare’s patents and have a strong claim that challenges their validity. In spite of this case, Instradent remains steadfast in delivering high quality, attractively-priced solutions to meet its customer and patient needs.”
As of October 1 2014, Neodent USA Inc. will be known as Instradent USA, Inc. Instradent was established in 2014 as a business platform to drive and manage the distribution and internationalization of specific brands for tooth replacement solutions, offering high quality, attractively-priced products, which are very popular in domestic and regional markets. Instradent's goal is to make them available to dental professionals internationally through its own growing network. Instradent has country organizations in the USA and Europe, set up to deliver superior quality at highly competitive prices and maximum customer convenience.
Instradent - Bright choice. Bright smiles.
Instradent USA, Inc. (Beginning October 1, 2014)
60 Minuteman Road Andover, MA 01810
Phone (855) 412-8883
Contact: Bill Benjaminsen: (978) 269-6366
Disclaimer: This release contains ‘forward-looking statements’, which reflect the current views of management and are subject to risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described here. Instradent is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in it.